Navigation Links
Hospira Reports Fourth-Quarter and Full-Year 2008 Results
Date:2/17/2009

ncy basis. Including the impact of foreign exchange, the company expects net sales to be relatively flat. Adjusted* diluted earnings per share for 2009 are expected to be in the range of $2.62 to $2.72.

The reconciliation between the projected 2009 adjusted* diluted earnings per share and GAAP diluted earnings per share follows:

    Diluted earnings per share -- adjusted*                    $2.62 - $2.72
                                                               --------------
    Estimated charges related to planned facilities
     optimization initiatives (mid-point of an estimated
     range of $0.10 to $0.12 per diluted share for 2009)              ($0.11)

    Estimated $53 million for the amortization of
     intangibles related to the Mayne Pharma acquisition              ($0.23)
                                                               --------------
    Diluted earnings per share -- GAAP                         $2.28 - $2.38
                                                               ==============

The company projects that cash flow from operations in 2009 will be in the $565 million to $615 million range. Depreciation and amortization is expected to be between $210 million and $220 million. Capital expenditures are projected to be between $155 million and $175 million.

"Our 2009 guidance aligns with our core strategies to improve margins and cash flow and invest for growth," said Begley. "We have a robust global generic drug pipeline and attractive growth opportunities in generic injectables. With our expanded GPO contracts, we expect to attract additional customers to our broad portfolio of products. We also expect continued momentum with MMS as we advance our technologically enhanced offerings. Through our streamlined, focused management and optimization initiatives, we are well positioned to advance our growth opportunities and drive sustainable long-
'/>"/>

SOURCE Hospira, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Related medicine news :

1. Hospiras Precedex(R) Phase IV Study Published in the Journal of the American Medical Association
2. Hospira to Host Conference Call for Fourth-Quarter 2008 Results and 2009 Projections
3. Hospira to Present at J.P. Morgans 27th Annual Healthcare Conference January 14
4. Hospira Names Ken Meyers to Lead Human Resources
5. Hospira Reports Third-Quarter 2008 Results
6. Hospira to Present at the 2008 Annual Credit Suisse Health Care Conference on November 12
7. FDA Approves New Indication for Hospiras Precedex (Dexmedetomidine HCL) Injection
8. Hospira Announces New Contracts With Premier Purchasing Partners for Infusion Devices, Solutions And Equipment
9. Hospira Reports Second-Quarter 2008 Results
10. Hospira Hosts Conference Call for Second-Quarter 2008 Earnings
11. Hospira Highlights Strategic Initiatives at Its 2008 Annual Meeting of Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... FL (PRWEB) , ... September 01, 2015 , ... ... and Drug Administration (FDA) for the treatment of androgenic alopecia in adults, announces ... brand new laser therapy cap, while also demonstrating its safety when used at ...
(Date:9/1/2015)... ... September 01, 2015 , ... According to a study ... 2 diabetes that participated in a three year study about weight loss and diabetes ... if they elected weight loss surgery at the onset of the trial. In fact, ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... not managed, stress created from everyday life changes can lead to very serious, ... provide support for coping with stress. Herbal supplement manufacturer MediHerb has ...
(Date:9/1/2015)... ... ... Philanthropic giving in the U.S. has been stuck at 2% GDP since the ... today by Camber Collective, goes to the root of this problem and provides a ... new philanthropic giving and shift $25B that’s already being donated, according to the report. ...
(Date:9/1/2015)... ... September 01, 2015 , ... Pharmaceutical ... different malignancies. Some options for cancer treatment are available belonging to various ... approach is necessary for effective treatment. Several molecules have been discovered out ...
Breaking Medicine News(10 mins):Health News:Capillus82™ Laser Therapy Cap Receives FDA Clearance for Treatment of Hair Loss 2Health News:Recent Journal Article on Diabetes Remission Adds to the Growing Pile Of Evidence in Favor of Bariatric Surgery, Says Dr. Feiz and Associates 2Health News:MediHerb Launches New Herbal Supplement to Help with the Challenges of Everyday Life 2Health News:MediHerb Launches New Herbal Supplement to Help with the Challenges of Everyday Life 3Health News:Camber Collective Releases Money for Good 2015 - Revealing Root Causes to Why Charitable Giving Has Been Stuck at 2% GDP Since the 70s 2Health News:Camber Collective Releases Money for Good 2015 - Revealing Root Causes to Why Charitable Giving Has Been Stuck at 2% GDP Since the 70s 3Health News:CD Antigen Cancer Market and Pipeline Landscape Examined in Comprehensive Kuick Research Report Published at MarketPublishers.com 2Health News:CD Antigen Cancer Market and Pipeline Landscape Examined in Comprehensive Kuick Research Report Published at MarketPublishers.com 3
... to set realistic expectations for patients undergoing knee and ... and patient expectations are sometimes not aligned. The study, ... American Academy of Orthopedic Surgeons held March 9-13 in ... be taken to bridge the expectation gap. This ...
... 10-year-old Sabrina Jo Spence, new research led by St. ... combat the drop in white blood cells following her ... an associate member of the St. Jude Department of ... Sabrina called her "happy dance." Sabrina is battling rhabdomyosarcoma. ...
... ... Simon, M.D. teach the keys to manifesting physical, emotional, and financial wellbeing. , ... Carlsbad, Calif. (PRWEB) March ... Deserve” –– a series of signature workshops led by best-selling authors, acclaimed mind-body healing ...
... ... disabilities and reveal new nationwide movement to promote ocular health awareness , ... San Diego, Calif. (PRWEB) March ... life changing assistive technologies for the blind and visually impaired, attends the California State ...
... ... Dr.Khanna , ... As you may know the Opinion Express is a highly respected monthly magazine that has gained ... with an emphasis on US, Indian and Middle Eastern news. , ,The publication has a ...
... ... ... ... ...
Cached Medicine News:Health News:Patient and doctor expectations from joint replacement surgeries not always aligned 2Health News:Patient and doctor expectations from joint replacement surgeries not always aligned 3Health News:Patient and doctor expectations from joint replacement surgeries not always aligned 4Health News:Research findings expected to ease treatment of low neutrophil counts in cancer patients 2Health News:The Chopra Center for Wellbeing Launches “Manifest the Life You Deserve” 2Health News:The Chopra Center for Wellbeing Launches “Manifest the Life You Deserve” 3Health News:The Chopra Center for Wellbeing Launches “Manifest the Life You Deserve” 4Health News:Optelec Gets Creative: CSUN San Diego and VisionZone Premier with Special Movie Debut 2Health News:Optelec Gets Creative: CSUN San Diego and VisionZone Premier with Special Movie Debut 3Health News:Opinion Express Labels Dr.Rajesh Khanna as the Doc with Midas Touch 2Health News:Worksite Wellness Magazine for the Electronic Age 2Health News:Worksite Wellness Magazine for the Electronic Age 3Health News:Worksite Wellness Magazine for the Electronic Age 4Health News:Worksite Wellness Magazine for the Electronic Age 5
(Date:9/1/2015)... Sept. 1, 2015  AccuTec Blades, Inc. today announced ... Blades division.  EPC announced in May 2015 its intent ... Verona, Virginia and Obregon, Mexico ... sale process. Rick Gagliano , ... Blades said, "Our new name, AccuTec Blades, reflects the ...
(Date:9/1/2015)... --NOWDiagnostics Inc., based in Springdale, Ark. , ... Canada , a move that brings the company ... have greater access to information concerning their health. ... blood-based rapid tests that allow health care providers to ... ailments and diseases. ZBx Corporation, a Toronto ...
(Date:9/1/2015)... DALLAS , Sept. 1, 2015 UT ... and distinguished faculty members joined U.S. Representatives ... in a roundtable discussion on the 21 st ... biomedical research currently being considered by the ... faculty – including National Academy of Sciences members, department ...
Breaking Medicine Technology:AccuTec Blades, Inc. Announces Acquisition of Industrial Blades Division from Edgewell Personal Care Company 2NOWDiagnostics Inc. Acquires Canada's ZBx Corporation 2NOWDiagnostics Inc. Acquires Canada's ZBx Corporation 3U.S. Rep. Michael C. Burgess, M.D., hosts roundtable at UT Southwestern to discuss pivotal 21st Century Cures Act and future of biomedical science 2U.S. Rep. Michael C. Burgess, M.D., hosts roundtable at UT Southwestern to discuss pivotal 21st Century Cures Act and future of biomedical science 3U.S. Rep. Michael C. Burgess, M.D., hosts roundtable at UT Southwestern to discuss pivotal 21st Century Cures Act and future of biomedical science 4U.S. Rep. Michael C. Burgess, M.D., hosts roundtable at UT Southwestern to discuss pivotal 21st Century Cures Act and future of biomedical science 5
... Conn., May 15, 2012 /PRNewswire-iReach/ -- Global ... important Cambridge Healthtech Institute conferences: IMVACS – ... August 13 – 15, Cambridge, MA - The ... under one heading: the Seventh Annual Novel Vaccines, Design ...
... Labs, Inc. (OTCQB/OTCBB: GOVX), a biotechnology company that creates, ... results for the three months ended March 31, 2012 ... delighted with recent developments that have strengthened and advanced ... David Dodd. "Our Phase 1/2 therapeutic vaccine trial continues ...
Cached Medicine Technology:Attendees Save up to $350 on CHI Conferences This Summer by Registering Through Global Information 2GeoVax Labs Reports 2012 First Quarter Financial Results 2GeoVax Labs Reports 2012 First Quarter Financial Results 3GeoVax Labs Reports 2012 First Quarter Financial Results 4GeoVax Labs Reports 2012 First Quarter Financial Results 5GeoVax Labs Reports 2012 First Quarter Financial Results 6
Straight shafts with 0.12 mm teeth and tying platform. Serrated handle with polished finish....
Angled 45 degree shafts with 1 x 2 teeth and 5 mm tying platform. Serrated handle with dull finish....
Heavy curved shafts with 2 x 2 teeth and crisscross serrated 6 mm tying platform. Serrated handle with polished finish....
Straight shafts with 1 x 2 teeth and 6 mm tying platform. Wide serrated handle with polished finish....
Medicine Products: